REGN•benzinga•
Piper Sandler Maintains Overweight on Regeneron Pharmaceuticals, Raises Price Target to $775
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga